Cancer Vaccines Market Anticipates Impressive Growth Trajectory at a CAGR of 36% During the Forecast Period (2026-2036) | DelveInsight

OSE2101Intismeran autogeneCYLEMBIOPositive

AI Analysis

Summary

Market analysis report projects cancer vaccine market growth at 36% CAGR through 2036, driven by novel therapies including OSE2101, Intismeran autogene, and CYLEMBIO from developers including Merck and Moderna.

Importance:2/10

Sentiment:

0.50

cancer vaccinesmarket growthimmunotherapy

Related Companies

$OSE.PA $MRK $MRNA

Read the original article

Published by PR Newswire Biotech on September 21, 2026 2:31 PM

Read Original